benzodiazepinones

Preferred Label : benzodiazepinones;

MeSH annotation : do not confuse with BENZODIAZEPINES;

Is substance : O;

Details

Origin ID

D001570;

UMLS CUI

C0005065;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Ne pas confondre avec
- benzodiazepines [MeSH Descriptor]
Record concept(s)
- benzodiazepinones [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,1'-((propane-1,3-diyl)dioxy)bis(7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5,11-dione) [MeSH Supplementary Concept]
- 1,3-bis(8-ethynyl-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxy)propyl diester [MeSH Supplementary Concept]
- 1-(2-fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)urea [MeSH Supplementary Concept]
- 1-(4-amino-3,5-dimethylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-amino-3-chlorophenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-aminophenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-aminophenyl)-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-butanoyl-(4-bis(2-chloroethyl)amino)phenylalanine ethyl ester)-7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 1-ethyl-2-(3-(1-ethylquinolin-2(1H)-ylidene)prop-1-enyl)-6-((6-oxo-6-((2-(2-(2-(4-(2-oxo-2-(6-oxo-5,6-dihydro-11H-pyrido(2,3-b)(1,4)benzodiazepin-11-yl)ethyl)piperazin-1-yl)ethoxy)ethoxy)ethyl)amino)hexanoyl)amino)quinolinium [MeSH Supplementary Concept]
- 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one [MeSH Supplementary Concept]
- 11-demethyltomaymycin [MeSH Supplementary Concept]
- 18-thia-6,14,16,19,20-pentaazapentacyclo(12.6.0.0(2,6).0(8,13).0(15,19))icosa-1(20),8,10,12,15-pentaene-7,17-dione [MeSH Supplementary Concept]
- 2,3-dihydro-1H-pyrrolo(2,1-c)(1,4)benzodiazepine-5,11(10H,11aH)-dione [MeSH Supplementary Concept]
- 2-(((3,5-difluorophenyl)acetyl)amino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide [MeSH Supplementary Concept]
- 2-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(3-methyl-4-oxo-4,5-dihydro-3H-benzo(d)(1,2)diazepin-5-yl)propanamide [MeSH Supplementary Concept]
- 2-(2-(3,5-difluorophenyl)-acetylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)propionamide [MeSH Supplementary Concept]
- 2-(3-(3-methoxy-4-nitrophenyl)-11-oxo-10,11-dihydro-5H-dibenzo(b,e)(1,4)diazepin-8-yl)-N,N-dimethylacetamide [MeSH Supplementary Concept]
- 2-methyl-5,6-dihydro-11H-pyrido(2,3b)(1,5)benzodiazepinone-5 [MeSH Supplementary Concept]
- 3,5-dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 3-((7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo(e)pyrrolo(1,2-a)(1,4)diazepin-8-yl)oxy)hexyl-1,2-dihydro-1gamma6-naphtho(1,8-cd)isothiazole-1,1-dione [MeSH Supplementary Concept]
- 3-(1-methyl-4-(1-methyl4-(1-methyl-4-(8-(2'-carboxamidoethyloxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one)pyrrole-2-carboxamido)pyrrole-2-carboxamido)pyrrole-2-carboxamido)propionamidine [MeSH Supplementary Concept]
- 3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)butyramide [MeSH Supplementary Concept]
- 3-acetylamino-N-(1-(((2-hydroxy-5-oxo-tetrahydrofuran-3-yl)carbamoyl)methyl)-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)succinamic acid [MeSH Supplementary Concept]
- 3-benzyl-1-(4-guanidinylphenyl)-4-phenyl-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 3-hydroxy-2-oxoquazepam [MeSH Supplementary Concept]
- 3-hydroxy-7-bromo-5-(ortho-chlorophenyl)-1,2-dihydro-3H-1,4-benzdiazepin-2-one [MeSH Supplementary Concept]
- 3-hydroxy-N-desalkyl-2-oxoquazepam [MeSH Supplementary Concept]
- 3-hydroxyhalazepam [MeSH Supplementary Concept]
- 4'-chlorodiazepam [MeSH Supplementary Concept]
- 4-(2-hydroxyphenyl)-1,5-benzodiazepin-2-one [MeSH Supplementary Concept]
- 4-(3-(2,6-dimethylpyridin-4-yl)phenyl)-7-methyl-8-trifluoromethyl-1,3-dihydrobenzo(b)(1,4)diazepin-2-one [MeSH Supplementary Concept]
- 4-methyl-5-ethoxalyl-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2-one [MeSH Supplementary Concept]
- 5-((4-(4-(diethylamino)butyl)-1-piperidinyl)acetyl)-10,11-dihydrobenzo(b,e)(1,4)diazepine-11-one [MeSH Supplementary Concept]
- 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro(3,2-e)-1,4-diazepin-2-one [MeSH Supplementary Concept]
- 7-((4-guanidinophenyl)aminocarbonyl)-3-oxo-4-phenethyl-1,4-benzodiazepine-2-acetic acid [MeSH Supplementary Concept]
- 7-(4-chlorophenyl)-8-phenoxy-4,5-benzo-3-aza-2-nonem [MeSH Supplementary Concept]
- 7-bromo-5-(2-chloro-6-hydroxyphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 7-bromo-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 7-bromo-5-(2-fluorophenyl)-3-methyl-1H-benzo(e)(1,4)diazepin-2(3H)-one [MeSH Supplementary Concept]
- 7-bromo-5-phenyl-4-propionyl-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1H-benzo(e)(1,4)diazepin-2(3H)-one [MeSH Supplementary Concept]
- 8-((6-(1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benzo(e)indol-3-yl)-6-oxohexyl)oxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one [MeSH Supplementary Concept]
- 8-(2,3-epoxypropoxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one [MeSH Supplementary Concept]
- 8-(5-(4-(trifluoromethyl)phenyl)-2,4-pentadienoylamino)benzolactam V [MeSH Supplementary Concept]
- 8-chloro-6-phenyl-4H-(1,2,4)-triazolo(4,3-a)(1,5)benzodiazepin-5(6H)-one [MeSH Supplementary Concept]
- 8-iodobretazenil [MeSH Supplementary Concept]
- 9-chloro-7-(2-chlorophenyl)-3,5-dihydro-(1,2,4)triazino(4,3-a)(1,4)benzodiazepin-2(1H)-one [MeSH Supplementary Concept]
- AHN 086 [MeSH Supplementary Concept]
- AQ-RA 741 [MeSH Supplementary Concept]
- BMS-871 [MeSH Supplementary Concept]
- BMS-906024 [MeSH Supplementary Concept]
- BMS-911557 [MeSH Supplementary Concept]
- CE-326597 [MeSH Supplementary Concept]
- CFM 1 [MeSH Supplementary Concept]
- CFM 2 [MeSH Supplementary Concept]
- CI 600 [MeSH Supplementary Concept]
- CRL-LS288 [MeSH Supplementary Concept]
- DF 594 [MeSH Supplementary Concept]
- DSB 120 [MeSH Supplementary Concept]
- DU 124884 [MeSH Supplementary Concept]
- FR 120480 [MeSH Supplementary Concept]
- FR 208419 [MeSH Supplementary Concept]
- GI 0122 [MeSH Supplementary Concept]
- HTH-01-015 [MeSH Supplementary Concept]
- ITH14001 [MeSH Supplementary Concept]
- KC 9048 [MeSH Supplementary Concept]
- L 365031 [MeSH Supplementary Concept]
- L 365260 [MeSH Supplementary Concept]
- L 740093 [MeSH Supplementary Concept]
- L 768673 [MeSH Supplementary Concept]
- LRRK2-IN1 [MeSH Supplementary Concept]
- LS-101 [MeSH Supplementary Concept]
- MLS002174161 [MeSH Supplementary Concept]
- N-(5-acetyl-7-cyano-4-methyl-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo(b)(1,4)diazepin-3-yl)-2-(methylamino)propanamide [MeSH Supplementary Concept]
- N-hydroxy-2-(7-(3-nitrophenoxy)-2,3,4,5-tetrahydrobenzo(1,2,5-f)thiadiazepine-1,1-dioxide)propanamide [MeSH Supplementary Concept]
- N-hydroxy-2-(7-benzyloxy-2,3,4,5-tetrahydrobenzo(1,2,5-f)thiadiazepine-1,1-dioxide)-4-methylpentanamide [MeSH Supplementary Concept]
- N-methylphenazepam [MeSH Supplementary Concept]
- N1-hydroxy-N8-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)octanediamide [MeSH Supplementary Concept]
- PAT(17)PZ compound [MeSH Supplementary Concept]
- PF 00477736 [MeSH Supplementary Concept]
- PF-04756956 [MeSH Supplementary Concept]
- RK 1441A [MeSH Supplementary Concept]
- RK 1441B [MeSH Supplementary Concept]
- RU 34030 [MeSH Supplementary Concept]
- S010-015 [MeSH Supplementary Concept]
- S010-018 [MeSH Supplementary Concept]
- SB 208651 [MeSH Supplementary Concept]
- SB 223245 [MeSH Supplementary Concept]
- SG 2285 [MeSH Supplementary Concept]
- SG2057 [MeSH Supplementary Concept]
- TDP 521252 [MeSH Supplementary Concept]
- TDP 665759 [MeSH Supplementary Concept]
- U 17660 [MeSH Supplementary Concept]
- UH-AH 37 [MeSH Supplementary Concept]
- XMD 8-92 [MeSH Supplementary Concept]
- YF 476 [MeSH Supplementary Concept]
- YM 26365 [MeSH Supplementary Concept]
- Z-360 [MeSH Supplementary Concept]
- ZG 63 [MeSH Supplementary Concept]
- asperlicin [MeSH Supplementary Concept]
- asperlicin B [MeSH Supplementary Concept]
- asperlicin C [MeSH Supplementary Concept]
- asperlicin D [MeSH Supplementary Concept]
- asperlicin E [MeSH Supplementary Concept]
- benzo(1,4)diazepin-2-one [MeSH Supplementary Concept]
- benzolactam V7 [MeSH Supplementary Concept]
- boseongazepine C [MeSH Supplementary Concept]
- bretazenil [MeSH Supplementary Concept]
- circumdatin A [MeSH Supplementary Concept]
- circumdatin B [MeSH Supplementary Concept]
- circumdatin E [MeSH Supplementary Concept]
- circumdatin H [MeSH Supplementary Concept]
- circumdatin I [MeSH Supplementary Concept]
- circumdatin J [MeSH Supplementary Concept]
- cyclopenin [MeSH Supplementary Concept]
- cyclopenol [MeSH Supplementary Concept]
- elfazepam [MeSH Supplementary Concept]
- flutoprazepam [MeSH Supplementary Concept]
- irazepine [MeSH Supplementary Concept]
- kenazepine [MeSH Supplementary Concept]
- meclonazepam [MeSH Supplementary Concept]
- neothramycin A [MeSH Supplementary Concept]
- neothramycin B [MeSH Supplementary Concept]
- neothramycins [MeSH Supplementary Concept]
- nuvenzepine [MeSH Supplementary Concept]
- oxotomaymycin [MeSH Supplementary Concept]
- propizepine [MeSH Supplementary Concept]
- ro 11-6893 [MeSH Supplementary Concept]
- ro 15-3505 [MeSH Supplementary Concept]
- ro 17-1812 [MeSH Supplementary Concept]
- ro 5-3335 [MeSH Supplementary Concept]
- ro 5-3663 [MeSH Supplementary Concept]
- ro 5-5807 [MeSH Supplementary Concept]
- ro 5-6669 [MeSH Supplementary Concept]
- ro 7-9749 [MeSH Supplementary Concept]
- ro 7-9957 [MeSH Supplementary Concept]
- rovalpituzumab tesirine [MeSH Supplementary Concept]
- sclerotigenin [MeSH Supplementary Concept]
- tetrahydro-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- tilivalline [MeSH Supplementary Concept]
- tomaymycin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients